In a novel theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the molecular chaos driving Alzheimer's disease. The condition causes widespread ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
Conductor Daniel Barenboim says he has been diagnosed with Parkinson's disease. The 82-year-old issued a statement Thursday ...
Our immune system is armed with an array of defenses designed to detect and eliminate harmful threats. One of its most powerful defense mechanisms is the complement system—a group of proteins that ...
Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, ...
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback